Golden State Medical Supply and Aurobindo – Recall of ranitidine
November 8, 2019 - The FDA announced a voluntary, consumer-level recalls of Aurobindo's prescription ranitidine due to unacceptable levels of N-nitrosodimethylamine (NDMA). Golden State Medical Supply has also announced a voluntary, consumer-level recall of prescription ranitidine.
Top